Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/22078
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOdnoletkova, I.-
dc.contributor.authorGoderis, G.-
dc.contributor.authorNobels, F.-
dc.contributor.authorFIEUWS, Steffen-
dc.contributor.authorAertgeerts, B.-
dc.contributor.authorAnnemans, L.-
dc.contributor.authorRamaekers, D.-
dc.date.accessioned2016-09-21T14:27:50Z-
dc.date.available2016-09-21T14:27:50Z-
dc.date.issued2016-
dc.identifier.citationDIABETIC MEDICINE, 33(6), p. 777-785-
dc.identifier.issn0742-3071-
dc.identifier.urihttp://hdl.handle.net/1942/22078-
dc.description.abstractAims To study the effect of a target-driven telecoaching intervention on HbA(1c) and other modifiable risk factors in people with Type 2 diabetes. Methods We conducted a randomized controlled trial in patients receiving hypoglycaemic agents. The primary outcome was HbA(1c) level at 6 months in the entire sample and in a subgroup with HbA(1c) levels >= 53 mmol/mol (7%) at baseline. Secondary outcomes were HbA(1c) at 18 months; total cholesterol, LDL, HDL, triglycerides, blood pressure, BMI and proportion of people who had achieved guideline-recommended targets at 6 and 18 months. Results A total of 287 participants were randomized to telecoaching and 287 to usual care. The mean (SD) baseline HbA(1c) level was 53 (11) mmol/mol [7.0 (1.0)%] overall and 63 (10) mmol/mol [7.9 (0.9)%] in the elevated HbA(1c) subgroup. At 6 months, the between-group differences in favour of telecoaching were: HbA(1c) -2 (95% CI -4; -1) mmol/mol [-0.2 (95% CI -0.3;-0.1)%; P = 0.003] overall and -4 (95% CI -7; -2) mmol/mol [-0.4 (95% CI -0.7; -0.2)%; P = 0.001] in the elevated HbA(1c) subgroup; BMI -0.4 kg/m(2) (95% CI -0.6; -0.1; P = 0.003); total cholesterol -6 mg/dl (95% CI -11; -1, P = 0.012). The proportion of participants on target for the composite of HbA(1c), LDL and blood pressure increased by 8.9% in the intervention group and decreased by 1.3% in the control group (P = 0.011). At 18 months, the difference in HbA(1c) was: -2 (95% CI -3;-0) mmol/mol [-0.2 (95% CI -0.3; -0.0)%; P = 0.046] overall and -4 (-7; -1) mmol/mol [-0.4 (95% CI -0.7; -0.1)%; P = 0.023] in the elevated HbA(1c) subgroup. Conclusion Nurse-led telecoaching improved glycaemic control, total cholesterol levels and BMI in people with Type 2 diabetes. Twelve months after the intervention completion, there were sustained improvements in glycaemic control.-
dc.description.sponsorshipThe present randomized controlled trial was subsidized by the European Regional Development Fund and the Flemish Government. Partena, MSD and Abbott provided a scientific grant for the clinical trial. Mesh and Tabakstop have provided measuring devices for the purposes of the trial. The funding sources played no role in any part of the study.-
dc.language.isoen-
dc.publisherWILEY-BLACKWELL-
dc.rights© 2016 Diabetes UK.-
dc.titleOptimizing diabetes control in people with Type 2 diabetes through nurse-led telecoaching-
dc.typeJournal Contribution-
dc.identifier.epage785-
dc.identifier.issue6-
dc.identifier.spage777-
dc.identifier.volume33-
local.format.pages9-
local.bibliographicCitation.jcatA1-
dc.description.notes[Odnoletkova, I.; Ramaekers, D.] Katholieke Univ Leuven, Leuven Inst Healthcare Policy, Leuven, Belgium. [Goderis, G.; Aertgeerts, B.] Katholieke Univ Leuven, Acad Ctr Gen Practice, Leuven, Belgium. [Nobels, F.] OLV Hosp Aalst, Dept Endocrinol, Moorselbaan, Aalst, Belgium. [Fieuws, S.] Univ Leuven, Interuniv Inst Biostat & Stat Bioinformat, Leuven, Belgium. [Fieuws, S.] Univ Hasselt, Leuven, Belgium. [Annemans, L.] Univ Ghent, Dept Publ Hlth, Ghent, Belgium.-
local.publisher.placeHOBOKEN-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1111/dme.13092-
dc.identifier.isi000379930200010-
item.fullcitationOdnoletkova, I.; Goderis, G.; Nobels, F.; FIEUWS, Steffen; Aertgeerts, B.; Annemans, L. & Ramaekers, D. (2016) Optimizing diabetes control in people with Type 2 diabetes through nurse-led telecoaching. In: DIABETIC MEDICINE, 33(6), p. 777-785.-
item.contributorOdnoletkova, I.-
item.contributorGoderis, G.-
item.contributorNobels, F.-
item.contributorFIEUWS, Steffen-
item.contributorAertgeerts, B.-
item.contributorAnnemans, L.-
item.contributorRamaekers, D.-
item.accessRightsRestricted Access-
item.validationecoom 2017-
item.fulltextWith Fulltext-
crisitem.journal.issn0742-3071-
crisitem.journal.eissn1464-5491-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
odnoletkova 1.pdf
  Restricted Access
Published version194.59 kBAdobe PDFView/Open    Request a copy
Show simple item record

SCOPUSTM   
Citations

18
checked on Sep 7, 2020

WEB OF SCIENCETM
Citations

51
checked on Aug 3, 2024

Page view(s)

66
checked on Sep 7, 2022

Download(s)

54
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.